company background image
BRAX.F logo

Braxia Scientific OTCPK:BRAX.F Stock Report

Last Price

US$0.0024

Market Cap

US$985.6k

7D

-19.7%

1Y

-59.2%

Updated

23 Dec, 2024

Data

Company Financials

Braxia Scientific Corp.

OTCPK:BRAX.F Stock Report

Market Cap: US$985.6k

BRAX.F Stock Overview

Operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. More details

BRAX.F fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Braxia Scientific Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Braxia Scientific
Historical stock prices
Current Share PriceCA$0.0024
52 Week HighCA$0.0088
52 Week LowCA$0.0013
Beta1.24
1 Month Change-35.53%
3 Month Change11.36%
1 Year Change-59.17%
3 Year Change-96.23%
5 Year Changen/a
Change since IPO-99.65%

Recent News & Updates

Recent updates

Shareholder Returns

BRAX.FUS HealthcareUS Market
7D-19.7%-1.0%-2.7%
1Y-59.2%-10.2%23.4%

Return vs Industry: BRAX.F underperformed the US Healthcare industry which returned -10.2% over the past year.

Return vs Market: BRAX.F underperformed the US Market which returned 23.4% over the past year.

Price Volatility

Is BRAX.F's price volatile compared to industry and market?
BRAX.F volatility
BRAX.F Average Weekly Movement46.8%
Healthcare Industry Average Movement7.6%
Market Average Movement6.3%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.2%

Stable Share Price: BRAX.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: BRAX.F's weekly volatility has increased from 34% to 47% over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/an/an/abraxiascientific.com

Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders. In addition, it is involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and development and acquisition of derivatives of ketamine and psilocybin, as well as other psychedelic products from its IP development platform.

Braxia Scientific Corp. Fundamentals Summary

How do Braxia Scientific's earnings and revenue compare to its market cap?
BRAX.F fundamental statistics
Market capUS$985.63k
Earnings (TTM)-US$9.64m
Revenue (TTM)US$2.21m

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BRAX.F income statement (TTM)
RevenueCA$2.21m
Cost of RevenueCA$1.89m
Gross ProfitCA$324.11k
Other ExpensesCA$9.96m
Earnings-CA$9.64m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.034
Gross Margin14.67%
Net Profit Margin-436.37%
Debt/Equity Ratio-29.6%

How did BRAX.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 09:47
End of Day Share Price 2024/12/20 00:00
Earnings2023/12/31
Annual Earnings2023/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Braxia Scientific Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution